COMBIPATCH

estradiol/norethindrone acetate transdermal system · Noven Therapeutics, LLC

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for COMBIPATCH, covering 2013-09-19 to 2024-02-15. Get the full timeline:

Most recent: FDA Approved: COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM) — Supplemental Application (Noven Therapeutics, LLC)